News for TELA Bio, Inc. (TELA)

Overview of the Recent Transaction Stonepine Capital Management, LLC (Trades, Portfolio), a prominent investment firm, recently made a strategic move by acquiri

**media[546950]**

Significant Stock Acquisition by Nantahala Capital Management On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) executed a notable tra

Transaction Overview On December 31, 2024, SILVERARC CAPITAL MANAGEMENT, LLC (Trades, Portfolio) made a significant move by acquiring an additional 1,940,721 sh

**media[523709]**

**media[491811]**

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ( TELA), a commercial-stage medical technology company focused on providing innovative soft-tis

**media[470877]**

TELA Bio, Inc. (NASDAQ:TELA) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsLouisa Smith - Vice President, Gilmartin...

Revenue: $19 million for Q3 2024, a 26% year-over-year increase.OviTex Revenue Growth: 23% increase in Q3 2024.OviTex PRS Revenue Growth: 31% increase in Q3 20

Nov 07, 2024 / 09:30PM GMTOperator Good afternoon, ladies and gentlemen and welcome to the Tela Bio third quarter, 2024. (Operators Instruction). I would now li

TELA Bio (TELA) delivered earnings and revenue surprises of -13.51% and 0.75%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Revenue: Achieved $19.0 million in Q3 2024, surpassing the analyst estimate of $18.85 million and marking a 26% increase year-over-year.Gross Profit: Reported

Overview of Recent Transaction by Stonepine Capital Management, LLC (Trades, Portfolio) On October 23, 2024, Stonepine Capital Management, LLC (Trades, Portfoli

The growth of the collagen peptide and gelatin market is primarily driven by increase in consumer awareness of health benefits, the aging population,...

The demand for advanced wound dressing is increasing owing to technological advancements, the increasing number of surgical procedures, and the rising...

Discover the ROTY Biotech Community, a platform for investors seeking valuable insights and recommendations in the ever-growing biotech industry.

Advanced Medical Solutions Group PLC on Monday said it has sealed an agreement with Pennsylvania-based medical technology designer and developer, Tela Bio Inc, to commercialise its LiquibandFix8...